← Back to Search

Sedation Methods for Colorectal Cancer Screening

N/A
Waitlist Available
Research Sponsored by East Bay Institute for Research and Education
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Scheduled and consented for screening or surveillance colonoscopy
Normal healthy patients or patients with mild systemic disease, ASA 1 or ASA 2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a method of doing colonoscopies without sedation in order to make the procedures more efficient. So far, the results show that the method is successful in 52% of cases and has benefits like shorter recovery time, better communication between patient and staff, and no need for next-day follow-up.

Who is the study for?
This trial is for adults over 50, both male and female, who are in good health or have mild systemic disease (ASA 1 or ASA 2). They must be scheduled for a colonoscopy for colorectal cancer screening or surveillance at the Sacramento VAMC, willing to be randomly assigned to a study method and agree to complete questionnaires. Those unable to consent or complete questionnaires due to language or other difficulties are excluded.
What is being tested?
The trial compares two methods of sedation during colonoscopy: the new 'study method' using water infusion instead of air insufflation versus the conventional method with air insufflation. It aims to see if the new method reduces medication needs, increases efficiency and patient willingness for future procedures, improves bowel preparation and polyp detection rate without compromising safety.
What are the potential side effects?
While not explicitly listed in the provided information, potential side effects may include discomfort from less sedation with the study method compared to conventional methods. There could also be risks associated with water infusion such as bloating or cramping.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a colonoscopy and have agreed to it.
Select...
I am generally healthy or have a mild health condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Water infusionExperimental Treatment1 Intervention
Water infusion in lieu of air insufflation during colonoscope insertion
Group II: Air insufflationActive Control1 Intervention
Conventional air insufflation colonoscopy

Find a Location

Who is running the clinical trial?

East Bay Institute for Research and EducationLead Sponsor
8 Previous Clinical Trials
474 Total Patients Enrolled

Media Library

Air insufflation Clinical Trial Eligibility Overview. Trial Name: NCT00920751 — N/A
Colorectal Cancer Screening Research Study Groups: Water infusion, Air insufflation
Colorectal Cancer Screening Clinical Trial 2023: Air insufflation Highlights & Side Effects. Trial Name: NCT00920751 — N/A
Air insufflation 2023 Treatment Timeline for Medical Study. Trial Name: NCT00920751 — N/A
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top